Date | Title | Description |
21.04.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
17.04.2025 | Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival | Precision Neuroscience announced that a core component of its brain implant system has been approved by the U.S. Food and Drug Administration.
The company is building a brain-computer interface that will eventually help paralyzed patients r... |
17.04.2025 | The China-U.S. trade war has investors bracing for more pain in both markets | - |
17.04.2025 | World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too" | MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women an... |
17.04.2025 | Lilly weight-loss pill works as well as Ozempic, shares surge | Lilly weight-loss pill works as well as Ozempic, shares surge
By Deena Beasley and Manas MishraApril 17, 20254:02 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The logo of Lilly is seen on a w... |
17.04.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
17.04.2025 | Goldman Sachs says buy call options on these stocks ahead of earnings | - |
17.04.2025 | 23andMe bankruptcy under congressional investigation for customer data | The House Committee on Energy and Commerce sent a letter to 23andMe expressing concern that its genetic data is “at risk of being compromised.”
The embattled genetic testing company filed for Chapter 11 bankruptcy protection in March, and i... |
16.04.2025 | Brace for more volatility with these defensive trades | - |
15.04.2025 | Key vaccine committee meets for the first time under Robert F. Kennedy Jr. | CDC official asks about COVID-19 vaccines
The conversation took a turn when a CDC official summarized a committee workgroup discussion about the waning COVID-19 pandemic, and asked whether the panel might consider changing vaccination recom... |
15.04.2025 | CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine | A day without major tariff developments from U.S. President Donald Trump’s administration is, for markets, a day of cautious optimism (or at least what passes as “optimism” in such unusual times). There was breathing room on Monday for mark... |
15.04.2025 | Назад, в генетическое будущее | - |
14.04.2025 | 5 things to know before the stock market opens Monday | Markets have been on a wild ride.
Trump exempted smartphones, computers and other tech devices and components from his so-called reciprocal tariffs.
Earnings season kicks off in earnest with big banks continuing to report along with Netflix... |
14.04.2025 | Pfizer halts development of weight-loss pill | - |
14.04.2025 | Stocks making the biggest moves premarket: Apple, Nvidia, Goldman Sachs, Pfizer and more | - |
14.04.2025 | Pfizer scraps daily weight loss pill after liver injury in one patient | Pfizer said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial.
The patient’s liver enzymes “recovered rapidly” after they stoppe... |
14.04.2025 | Pfizer ends development of potential pill obesity treatment | But leading treatments like Zepbound and Novo Nordisk’s Wegovy are injectable. Drugmakers are eager to develop an easier-to-take pill version for patients who don’t want to deal with needles and daily injections.
Lilly researchers expect to... |
13.04.2025 | Goldman says these names can rally this earnings season after likely topping expectations | - |
12.04.2025 | The Melanoma Research Foundation to host the DC Miles for Melanoma 5K | The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we w... |
11.04.2025 | Tariff Turmoil: The Unraveling of U.S.-China Trade Relations and Its Impact on the Aerospace Industry | The world of trade is a chess game, and right now, the pieces are scattered. The U.S. and China are locked in a fierce battle, and the stakes are high. Tariffs are the weapons of choice, and the aerospace industry is caught in the crossfire... |
11.04.2025 | Cramer looks at what’s holding the market back — plus, stocks that should be doing better | - |
11.04.2025 | China will raise tariffs on US goods from 84% to 125%, the latest in an escalating trade war | Chinese tariffs will affect goods like soybeans, aircrafts and their parts and drugs — all among the country’s major imports from the U.S. Beijing, meanwhile, suspended sorghum, poultry and bonemeal imports from some American companies last... |
10.04.2025 | Tariff Turmoil: The Pharmaceutical Industry Faces a Storm | The pharmaceutical industry is in the eye of a storm. President Donald Trump has thrown a wrench into the works with his proposed tariffs on drug imports. The news sent shockwaves through global markets, causing shares of major pharmaceutic... |
10.04.2025 | Global pharma shares plunge as Trump doubles down on tariff threat | Global drugmakers' stocks dropped across the board after US President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain, and as his country-specific recipro... |
10.04.2025 | Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week | Global initiative addressing personalised and preventative health to be launched during the event
ABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised and effective healthcare solutions, the Departm... |
09.04.2025 | Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more | - |
09.04.2025 | Pharmaceutical stocks rise as Trump pauses tariffs but not for China | Some pharmaceutical stocks rose after President Donald Trump said he would pause most so-called reciprocal tariffs, temporarily easing fears about the impact of potential tariffs on pharmaceuticals .
Shares of most U.S.-based companies turn... |
09.04.2025 | Anthropic steps up competition with OpenAI, rolls out $200 per month subscription | Anthropic on Wednesday introduced Claude’s Max plan, a new subscription tier for its viral chatbot and ChatGPT competitor.
The plan has two price points — $100 per month or $200 per month — offering different amounts of usage.
Subscribers w... |
08.04.2025 | Quality, long-term stocks to buy during the sell-off, according to UBS | - |
06.04.2025 | U.S. stocks bearing the brunt of trillions in market value losses around the globe | - |
04.04.2025 | What to know about tariffs after Trump launches trade war | Please subscribe to IBJ to decode this article.
e pscnswlpe ga niS s eihh boehr’edgaarnhgaosu.ooe trt srr tUtat ai masctsgdhrnden iiennn tategniaaDtiPdwyld tmoi alrnEae o eenleT r dneanuidn,od nsiTrdpelumtnA
chedxa mar rtah fytatstwortesro ... |
04.04.2025 | Stocks with the most to lose as U.S.-China trade war breaks out | - |
03.04.2025 | What value investor Bill Nygren is scooping up during the market rout | - |
03.04.2025 | Playing defense: These stable stocks should be trade war-proof and generate income | - |
02.04.2025 | Latest Innovation in Automation and AI/ML Presented at the 11th Annual Biopharma Partner Symposium | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D.
Top biopharmas and leading biotechs discuss new trends in AI/ML and share how th... |
01.04.2025 | Global Times: China remains an 'ideal, secure and promising' destination for foreign investors: Xi | BEIJING, April 1, 2025 /PRNewswire/ -- As China wraps up a week in which it hosted two top-level international forums - the China Development Forum (CDF) 2025 and the Boao Forum for Asia (BFA) Annual Meeting 2025 - to drive home its commitm... |
01.04.2025 | Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks | - |
01.04.2025 | Stocks that can best manage the tariff threat, according to Morgan Stanley | - |
01.04.2025 | Wells Fargo calls a drug stock and a bank buys — here's why we agree | - |
01.04.2025 | JPMorgan’s top stock picks as April kicks off | - |
31.03.2025 | The TikTok Tug-of-War: A Dance of Power and Profit | The saga of TikTok in the United States is a high-stakes drama. It’s a dance between corporate giants, government regulations, and the ever-watchful eyes of the public. As the clock ticks down to a crucial deadline, the future of this popul... |
31.03.2025 | Navigating the Crossroads: China’s Call for Global Business Unity Amid Trade Tensions | In the heart of Beijing, a significant meeting unfolded. Chinese President Xi Jinping gathered top executives from around the globe. The atmosphere was charged with urgency. Trade tensions with the United States loom large. Yet, Xi painted ... |
31.03.2025 | How the stock market may react to different tariff scenarios this week | - |
31.03.2025 | Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies | Key Highlights:
Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD).
ivonescimab outperforms pembrolizu... |
28.03.2025 | Ampersand Biomedicines: Series B Raised For Developing Smarter Medicines | Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, announced it has secured $65 million in Series B funding from investors including Ampersand... |
28.03.2025 | These are analysts' favorite S&P 500 stocks as the second quarter approaches | - |
28.03.2025 | China’s Xi calls on top executives to help ‘uphold global order’ as trade tensions with U.S. rise | Chinese President Xi Jinping met with foreign executives on Friday in Beijing and emphasized that the country was a safe and stable place for companies.
Business leaders Xi met included Bridgewater Associates’ Ray Dalio, Standard Chartered ... |
28.03.2025 | These dividend stocks will benefit from longevity’s ‘transformational’ opportunity, UBS says | - |
26.03.2025 | Sepsis Alliance Survey Reveals Gaps in Antimicrobial Resistance Training Among Registered Nurses | Antimicrobial resistance is considered to be a dangerous and growing problem - what kind of training do registered nurses receive on this terrifying threat?
SAN DIEGO, March 26, 2025 /PRNewswire-PRWeb/ -- A recent survey conducted by Sepsis... |
26.03.2025 | CHOSA to Unveil Predictive Data for Cisplatin Response in Lung Cancer at end Q2 2025 – Advancing Precision Medicine for the World’s Most Widely Used Cancer Drug | CHOSA to Unveil Predictive Data for Cisplatin Response in Lung Cancer at end Q2 2025 – Advancing Precision Medicine for the World’s Most Widely Used Cancer Drug
Wed, Mar 26, 2025 14:11 CET Report this content
The English text is an unoffici... |
25.03.2025 | The Weight of Expectations: A Look at the Obesity Drug Market's Rollercoaster Ride | The obesity drug market is a battleground, where hopes soar and plummet with each trial result. Recent developments from Novo Nordisk and Eli Lilly illustrate this volatile landscape. Both companies are vying for dominance in a sector proje... |
24.03.2025 | Beijing pledges greater market access as top global CEOs gather at the China Development Forum | China’s Vice Premier He Lifeng has reassured foreign business leaders that Beijing will continue to open up its market and welcome more investment from multinational companies, according to a readout from the Ministry of Commerce.
Foreign C... |
24.03.2025 | Eli Lilly will soon release key data on its weight loss pill. Here’s why it could be a game-changer | Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year.
The trial results are among the pharmaceutical industry’s most critical of the year, as... |
24.03.2025 | China touts business potential to US companies despite 'rising instability' | China touts business potential to US companies despite 'rising instability'
By Liz LeeMarch 24, 20259:35 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
China says it will conti... |
24.03.2025 | Cushion your portfolio in rocky times with these buy-rated dividend payers, Goldman says | - |
23.03.2025 | Oppenheimer’s best stock picks heading into April | - |
22.03.2025 | Johnson & Johnson's Bold $55 Billion Bet on U.S. Manufacturing | In a world where uncertainty looms, Johnson & Johnson (J&J) stands firm. The pharmaceutical giant has announced a staggering investment of over $55 billion in the United States over the next four years. This move is not just a finan... |
22.03.2025 | America needs a jab in its corporate backside | - |
21.03.2025 | The Biotech Boom and the Opioid Reckoning: A Tale of Two Industries | In the heart of Europe, a new wave of biotech innovation is rising. Sofinnova Partners has closed a €165 million fund, the Sofinnova Biovelocita II. This fund is a beacon for startups, illuminating the path for groundbreaking therapies. It’... |
21.03.2025 | J&J увеличивает инвестиции в США до более чем $55 млрд на фоне угроз введения пошлин | J&J заявила, что один из новых заводов будет построен в Уилсоне, Северная Каролина, где фармацевтический гигант официально заложил фундамент в пятницу, но не раскрыла, где будут построены остальные. Производитель лекарств и медицинских ... |
21.03.2025 | NVIDIA GTC: AI Innovation Driving Change in Healthcare and Drug Discovery | - |
20.03.2025 | Steady stocks that beat the market during rough times, according to Bank of America | - |
20.03.2025 | The aging population is a $1 trillion opportunity. These stocks are the winners, says Mizuho | - |
20.03.2025 | Friday’s big stock stories: What’s likely to move the market in the next trading session | - |
19.03.2025 | Sofinnova Partners: €165M Biotech Acceleration Fund Closed | Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the final close of Sofinnova Biovelocita II. This fund has exceeded its target, successfully raising €165 million, with s... |
19.03.2025 | Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement | Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement
By Dietrich KnauthMarch 19, 20259:00 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Bottles of prescription painkiller... |
19.03.2025 | Pfizer продает всю долю в Haleon за $3,24 млрд | В рамках сделки производитель препарата Sensodyne, компания Haleon, согласилась выкупить 44 миллиона акций у Pfizer, своего крупнейшего акционера на данный момент, а 618 миллионов акций будут проданы институциональным инвесторам.
Общая сумм... |
19.03.2025 | Pfizer sells entire Haleon stake for $3.24 billion | Pfizer sells entire Haleon stake for $3.24 billion
By ReutersMarch 19, 20257:36 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The Pfizer logo is seen outside the pharmaceutical company’s manuf... |
18.03.2025 | Goldman recommends these cheap and stable stocks to survive the market volatility | - |
18.03.2025 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
18.03.2025 | 3 technical indicators to watch as stocks try to find a bottom | - |
17.03.2025 | Health | Scientists say NIH officials told them to scrub mRNA references on grants | Scientists relayed their experiences on the condition of anonymity for fear of professional retaliation by the Trump administration.
A senior official at the National Cancer Institute confirmed that NIH acting Director Matthew Memoli sent a... |
17.03.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
15.03.2025 | Drugmakers agree to participate in second round of price negotiations | Drugmakers agree to participate in second round of price negotiations
By ReutersMarch 14, 202511:02 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 FILE PHOTO: A view shows the logo ... |
15.03.2025 | Kohl's changes DEI officer title, broadens supplier diversity program | Kohl's changes DEI officer title, broadens supplier diversity program
By ReutersMarch 14, 20259:41 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The logo and trading informations for Kohl's is... |
14.03.2025 | Tariff Turbulence: The Ripple Effect on U.S. Businesses | In the whirlwind of global trade, tariffs are the storm clouds gathering on the horizon. President Donald Trump’s recent threats of $1.4 trillion in tariffs have sent shockwaves through corporate America. Companies are scrambling to adapt, ... |
13.03.2025 | Donald Trump’s $1.4 trillion tariff threats scramble business plans, US companies form task-forces to tackle impact | Ozempic-maker Novo Nordisk A/S is planning to make more of its medicines for the US market in the country; Boeing Co. risks a gummed up supply chain and higher aircraft costs it may not be able to pass on; Chinese online retailer Shein Grou... |
13.03.2025 | Here’s why I’m pounding the table for stocks in this Trump-driven market sell-off | - |
13.03.2025 | Jim Cramer’s 6 favorite stocks right now, plus updates on the rest of the portfolio | - |
13.03.2025 | Copute Partners The Ignition AI Accelerator, a Collaboration Among NVIDIA, Tribe, and DISG, Drive Innovations in Decentralised AI | SINGAPORE, March 13, 2025 /PRNewswire/ -- The Ignition AI Accelerator, a collaboration between NVIDIA, Tribe, and Digital Industry Singapore (DISG), announces its partnership with Copute, a pioneering Web3 ecosystem dedicated to decentralis... |
12.03.2025 | Goldman gave clients a stable stock list to buy if there’s a recession. Here’s what’s on it | - |
12.03.2025 | Wednesday’s big stock stories: What’s likely to move the market in the next trading session | - |
12.03.2025 | Выпускайте субстанцию: фарма ищет лучшую версию себя | - |
11.03.2025 | Trump’s tariffs are still rocking markets. Here’s how strategists advise protecting your portfolios | - |
10.03.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
08.03.2025 | Goldman names the most ‘compelling’ stocks on Wall Street right now | - |
07.03.2025 | TRIMTECH Therapeutics: A New Dawn in Neurodegenerative Disease Treatment | In the heart of Cambridge, a biotech revolution is brewing. TRIMTECH Therapeutics has emerged as a beacon of hope for those grappling with neurodegenerative diseases. With a recent funding boost of €28.6 million, the company is poised to ta... |
06.03.2025 | Jim Cramer buys stocks during the market sell-off as he tries to make sense of it all | - |
06.03.2025 | TRIMTECH Therapeutics raises €28.6 million for treatment of neurodegenerative diseases | Cambridge-based TRIMTECH Therapeutics, a BioTech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, announced the closing of its €28.6 million Seed funding round.
The financing was led by ... |
06.03.2025 | These stocks are the best insulated from Trump's tariffs, according to Barclays | - |
06.03.2025 | Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research | - |
04.03.2025 | Китай и США разгоняют мировой госдолг | - |
04.03.2025 | Best stocks to own during a trade war, according to Evercore ISI | - |
04.03.2025 | Amazon-backed Anthropic valued at $61.5B post Series E funding round | Amazon-backed AI company Anthropic has raised $3.5 billion in its Series E round with a post-money valuation of $61.5 billion.
The round was led by Lightspeed Venture Partners and also saw participation from Bessemer Venture Partners, D1 ... |
04.03.2025 | Anthropic: AI Research Company Raises $3.5 Billion At $61.5 Billion Valuation | AI safety and research company Anthropic has raised $3.5 billion at a $61.5 billion post-money valuation. The funding round was led by Lightspeed Venture Partners, and participants included Bessemer Venture Partners, Cisco Investments, D1 C... |
03.03.2025 | Amazon-backed AI firm Anthropic valued at $61.5 billion after latest round | Anthropic on Monday closed its latest funding round at a $61.5 billion post-money valuation, the company confirmed to CNBC.
The $3.5 billion round was led by Lightspeed Venture Partners, and other investors included Salesforce Ventures and ... |
01.03.2025 | Navigating the New Standards of Quality Culture in Pharma and the Digital Landscape of No-Code Solutions | In the ever-evolving worlds of pharmaceuticals and digital technology, two recent developments stand out. One is a new standard for quality culture in the pharmaceutical industry. The other is a significant acquisition in the no-code websit... |
01.03.2025 | The New Frontier of Cancer Treatment: Akeso and Summit Therapeutics Join Forces with Pfizer | In the relentless battle against cancer, innovation is the lifeblood that fuels hope. Akeso, Inc., a biopharmaceutical trailblazer, has announced a significant collaboration with Summit Therapeutics and Pfizer. This partnership aims to expl... |
01.03.2025 | The Future of Cancer Treatment: A New Dawn with Ivonescimab and ADCs | In the ever-evolving landscape of cancer treatment, innovation is the lifeblood that fuels hope. Akeso, Inc. has stepped into the spotlight with its groundbreaking collaboration with Summit Therapeutics and Pfizer. This partnership aims to ... |
27.02.2025 | Vrai Raises €5M in Funding | Vrai, a Dublin, Ireland-based simulation data company, raised €5M in funding.
The round was led by Beringea with participation from Enterprise Ireland, Northstar Ventures and a number of Irish family offices.
The company intends to use the ... |